This is consistent with the previous assertion that EGFR and KRAS mutations are mutually exclusive in NSCLC, although some cases of EGFR and KRAS mutations being present together in some Asian populations, including in China, have been reported [25,36]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.